News
St. Luke’s University Health Network Wins 2020 Premier Alliance Excellence Award
Premier Inc. (NASDAQ: PINC) has named St. Luke’s University Health Network, a fully integrated, nationally recognized health network serving Pennsylvania and New Jersey, the winner of the 2020
AMN CEO Susan Salka Named One of Modern Healthcare’s 100 Most Influential People of 2020
Susan Salka, President and CEO of AMN Healthcare (NYSE:AMN), has been named by Modern Healthcare as one of 2020’s 100 Most Influential People. This year’s list focused on people who influenced the
LivaNova Announces Board Appointment and Board Leadership Changes
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company’s governance.
Todd Schermerhorn has been appointed
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced it has
QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the launch of its QuantiFERON SARS-CoV-2 RUO solution that can detect T-cell responses of the human immune system to the
QIAGEN führt QuantiFERON SARS-CoV-2 ein, Test zur Erforschung von Ursachen, Verbreitung und Kontrolle von COVID-19 durch T-Zell-Reaktion
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Markteinführung der QuantiFERON SARS-CoV-2 RUO-Lösung bekannt, mit der T-Zell-Reaktionen des menschlichen Immunsystems auf den
Xencor Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid Leukemia at the 2020 ASH Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced updated data
LivaNova und Gyrus Capital schließen Vereinbarung über den Kauf des Herzklappengeschäfts
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Medizintechnik- und Innovationsunternehmen, und Gyrus Capital (Gyrus), eine Investmentfirma, die sich auf Investitionen im Gesundheits- und
LivaNova to Host Satellite Symposium on Advances in Neuromodulation at American Epilepsy Society AES2020 Virtual Event
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will host “Updates and Advances in Neuromodulation,” a satellite symposium at AES2020, the
Premier Inc. to Participate in the Guggenheim Digital Health Virtual Summit on December 8, 2020
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the Guggenheim Digital
AMN Healthcare Names James Taylor as Group President and Chief Operating Officer for Physician & Leadership Solutions
AMN Healthcare (NYSE: AMN) has named James Taylor as its new Group President and Chief Operating Officer for Physician & Leadership Solutions.
This press release features multimedia. View the full
LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability
AMN Healthcare Announces Initiative to Support Minority-owned Businesses
To elevate and accelerate the growth of Minority-owned businesses, AMN Healthcare (NYSE: AMN) launched the AMN Diverse Business Pledge to help minority-owned businesses obtain Minority Business
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
Regulatory News:
Vifor Pharma is marking the sixth anniversary of Iron Deficiency Day, focused on raising international awareness of the serious health impact of iron deficiency and iron
LivaNova to Present at the Berenberg European Conference 2020
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Berenberg European
Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference
Novocure (NASDAQ: NVCR) announced today that Novocure’s Executive Chairman William Doyle and Chief Science Officer Dr. Uri Weinberg will participate in the 3rd Annual Evercore ISI 2020 Virtual
Genus plc Provides Update on Fiscal 2021 Financial Performance
Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the period from July 1, 2020 through November 24, 2020
LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper Sandler 32nd Annual
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields will be featured at the Society for Neuro-Oncology 2020 Virtual Annual Meeting on November 19 through November 21
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118005914/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic –
QIAGEN arbeitet mit BioNTech an der Entwicklung eines Begleitdiagnostikums zur Identifizierung von HPV-assoziierten Plattenepithelkarzinomen in der Kopf-Hals-Region
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, im Rahmen einer strategischen Zusammenarbeit gemeinsam mit der BioNTech SE (Nasdaq: BNTX) ein gewebebasiertes
ProvideGx® Partners with Fresenius Kabi to Help Stabilize Supply of Heparin, a Vital Medication
Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Fresenius Kabi to supply pre-filled, single-use IV bags of heparin sodium injection, USP to healthcare providers
QIAGEN führt NeuMoDx-Multiplex-Test zur Vervollständigung des SARS-CoV-2-Testportfolios in Europa und weiteren Märkten ein
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung des NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Tests bekannt gegeben, mit dem medizinische Fachkräfte häufige saisonal
QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that will help healthcare professionals quickly